| Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; squadron lateral retractor designed to maximize patient outcomes; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System designed to improve surgical efficiency without compromising accuracy. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; solanas posterior cervico/thoracic fixation system and avalon occipital plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier. Further, it develops EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is based in Carlsbad, California. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| TULLIS JAMES L L | Director | Apr 07 | Sale | 12.99 | 67,690 | 879,293 | 547,974 | Apr 11 06:54 PM | | TULLIS JAMES L L | Director | Apr 07 | Sale | 12.99 | 1,630 | 21,174 | 161,512 | Apr 11 06:54 PM | | Pritzker Jennifer N. | 10% Owner | Mar 11 | Buy | 10.64 | 1,100 | 11,704 | 3,731 | Mar 15 05:44 PM | | Pritzker Jennifer N. | 10% Owner | Mar 08 | Buy | 11.46 | 2,000 | 22,910 | 4,000 | Mar 10 06:41 PM | | Pritzker Jennifer N. | 10% Owner | Mar 08 | Buy | 11.42 | 2,000 | 22,840 | 42,200 | Mar 10 06:41 PM | | Lish Scott | SVP, DEVELOPMENT | Mar 01 | Sale | 10.94 | 5,100 | 55,794 | 323,342 | Mar 03 06:00 PM | | Lish Scott | SVP, Development | Feb 22 | Sale | 9.66 | 4,760 | 45,982 | 260,350 | Feb 24 08:52 PM | | Koning John Todd | Chief Financial Officer | Dec 16 | Buy | 11.17 | 5,000 | 55,850 | 196,682 | Dec 20 12:28 PM | | Hochberg Jason | Director | Dec 15 | Buy | 10.84 | 5,000 | 54,200 | 84,375 | Dec 16 04:33 PM | | Pritzker Jennifer N. | 10% Owner | Dec 10 | Buy | 11.66 | 3,000 | 34,990 | 3,000 | Dec 13 07:38 PM | | Pritzker Jennifer N. | 10% Owner | Dec 10 | Buy | 11.79 | 1,000 | 11,790 | 40,200 | Dec 13 07:38 PM | | TULLIS JAMES L L | Director | Dec 10 | Sale | 11.65 | 55,000 | 640,750 | 470,747 | Dec 13 07:36 PM | | Pritzker Jennifer N. | 10% Owner | Dec 09 | Buy | 12.18 | 1,000 | 12,180 | 39,200 | Dec 13 07:38 PM | | TULLIS JAMES L L | Director | Dec 09 | Sale | 11.78 | 20,000 | 235,600 | 525,747 | Dec 13 07:36 PM | | Bakst Evan | Director | Nov 26 | Buy | 10.57 | 10,000 | 105,700 | 786,361 | Nov 30 12:19 PM | | Segal Paul | 10% Owner | Nov 24 | Buy | 11.17 | 100,000 | 1,117,000 | 167,496 | Nov 26 09:08 PM | | Segal Paul | 10% Owner | Nov 23 | Buy | 10.09 | 67,496 | 681,035 | 67,496 | Nov 26 09:08 PM | | Hochberg Jason | Director | Nov 23 | Buy | 10.83 | 5,000 | 54,150 | 79,375 | Nov 24 03:22 PM | | Mowry David H | Director | Nov 16 | Sale | 12.25 | 14,254 | 174,612 | 77,797 | Nov 17 04:00 PM | | Hunsaker Craig E | EVP, People/Culture & GC | Nov 12 | Buy | 11.66 | 15,000 | 174,900 | 1,057,109 | Nov 15 07:04 PM | | Sponsel David | EVP, Sales | Nov 12 | Sale | 11.56 | 9,847 | 113,831 | 541,765 | Nov 15 08:26 PM | | Miles Patrick | CEO | Nov 11 | Buy | 11.71 | 50,000 | 585,500 | 5,103,837 | Nov 15 07:03 PM | | Pelizzon David R | Director | Nov 11 | Buy | 11.41 | 4,366 | 49,816 | 288,849 | Nov 15 07:02 PM | | Lish Scott | SVP, Development | Nov 10 | Sale | 11.79 | 6,250 | 73,688 | 265,110 | Nov 15 07:34 PM | | Pelizzon David R | Director | Nov 08 | Buy | 13.00 | 5,425 | 70,525 | 284,483 | Nov 10 02:38 PM | | Pritzker Jennifer N. | 10% Owner | Aug 27 | Buy | 13.26 | 2,000 | 26,520 | 2,000 | Aug 31 08:00 PM | | Pritzker Jennifer N. | 10% Owner | Aug 17 | Buy | 12.62 | 554 | 6,991 | 1,631 | Aug 17 06:38 PM | | Pritzker Jennifer N. | 10% Owner | Aug 13 | Buy | 12.99 | 1,077 | 13,990 | 1,077 | Aug 17 06:38 PM | | Pritzker Jennifer N. | 10% Owner | Aug 11 | Buy | 13.13 | 1,000 | 13,130 | 38,200 | Aug 11 06:11 PM | | Pritzker Jennifer N. | 10% Owner | Aug 09 | Buy | 14.69 | 3,000 | 44,070 | 2,725,805 | Aug 11 06:11 PM | | Pritzker Jennifer N. | 10% Owner | Aug 09 | Buy | 14.68 | 1,000 | 14,680 | 37,200 | Aug 11 06:11 PM | | Miles Patrick | CEO | Aug 06 | Option Exercise | 2.00 | 250,000 | 500,000 | 5,053,837 | Aug 09 11:17 AM | | Lish Scott | SVP, Development | Aug 03 | Sale | 14.24 | 10,000 | 142,400 | 288,402 | Aug 05 08:04 PM | | Lish Scott | SVP, Development | Jul 12 | Sale | 16.46 | 11,965 | 196,944 | 298,402 | Jul 20 12:32 PM | | L-5 Healthcare Partners, LLC | Director by deputization | Jun 16 | Option Exercise | 3.50 | 400,000 | 1,400,000 | 8,336,508 | Jun 16 05:39 PM | | Sponsel David | EVP, Sales | Jun 16 | Sale | 14.78 | 10,000 | 147,800 | 554,317 | Jun 21 02:17 PM |
|
